Contribution of rapid lateral flow assays from capillary blood specimens to the diagnosis of COVID-19 in symptomatic healthcare workers: a pilot study in a university hospital, Paris, France

Diagn Microbiol Infect Dis. 2021 Oct;101(2):115430. doi: 10.1016/j.diagmicrobio.2021.115430. Epub 2021 May 18.

Abstract

Background: This study aimed to assess, by rapid tests, the immune status against COVID-19 among Healthcare Workers (HCW) with history of symptoms, and for whom SARS-CoV-2 detection was either not documented or negative.

Methods: Whole blood by finger prick and serum samples were taken from HCW for use with 2 rapid lateral flow tests and an automated immunoassay.

Results: Seventy-two HCWs were included, median duration between symptoms onset and serology sampling was 68 days. Anti-SARS-CoV-2 antibodies were detected by rapid test in 11 HCW (15.3%) and confirmed in the 10 with available serum by the automated immunoassay. The frequency of ageusia or anosmia was higher in participants with SARS-CoV-2 antibodies (P = 0.0006 and P = 0.029, respectively).

Conclusions: This study, among symptomatic HCW during the first wave in France, showed that 15% had IgG anti-SARS-CoV-2, a higher seroprevalence than in the general population. Rapid lateral flow tests were highly concordant with automated immunoassay.

Keywords: SARS-CoV-2; healthcare workers; rapid lateral flow test; serology.

MeSH terms

  • Adult
  • Antibodies, Viral / blood
  • COVID-19 / blood
  • COVID-19 / diagnosis*
  • COVID-19 Serological Testing*
  • Female
  • Health Personnel*
  • Humans
  • Immunoassay
  • Male
  • Middle Aged
  • Paris / epidemiology
  • Pilot Projects
  • Point-of-Care Testing*
  • Prospective Studies
  • SARS-CoV-2 / immunology
  • SARS-CoV-2 / isolation & purification*
  • Sensitivity and Specificity
  • Seroepidemiologic Studies

Substances

  • Antibodies, Viral